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SUMMARY
In order to achieve optimum health status, Type 2 Diabetes (T2D) patients are usually encouraged to undergo
regular and consistent therapeutic exercises. This study investigated whether the gains of exercises on adiposity
variables of T2D patients are maintained within a few weeks of withdrawal from exercise and whether it was
significantly related to the age of the patient and the duration of diagnosis of T2D.
Forty-threeT2D patients aged between 30 and 64 years were recruited for this study. They were placed on a
combination of endurance and strengthening exercises for 12 weeks. The participants were thereafter observed for
another 12 weeks without exercises. The adiposity variables measured in both phases of the study include: body
mass index (BMI), waist circumference (WC), waist-hip-ratio (WHR) and percent-body-fat (PBF). 
Significant improvements (P<0.05) for all the variables were achieved after 12 weeks of therapeutic exercises.
The variables, however, showed significant relapses (P<0.05) within six weeks of withdrawal of exercise and these
 were significantly related (P<0.05) to both the age of the patient and the duration of diagnosis.
The endurance and strengthening exercises improved the adiposity variables of theT2D patients, but the gains
began to decline within six weeks of withdrawal from the exercises. The increase in adiposity was more as the age
and duration of diagnosis of the patients increased. 
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INTRODUCTION
Formerly, diabetes was seen mostly in developed nations,
but the disease is becoming commonplace in developing 
countries, where lifestyle practices have begun to emulate 
those of developed societies (King and Herman, 1998).
With the modernization taking place, the lifestyle in many
sub-Saharan African countries, particularly in urban areas,
is similar to those in many Western countries, with the 
related epidemiological changes (Kengne et al, 2005).
Generally, a number of factors are implicated in the
pathogenesis of diabetes. Obesity contributes significantly
to the burden of diabetes and other chronic health
conditions (Kengne  et al, 2005). Adiposity and level of
physical activity are also significant and independent 
determinants of insulin sensitivity and secretion. A high 
degree of adiposity and a small proportion of time spent in 
physical activity are associated with low insulin sensitivity 
and high insulin secretion (Snitker et al, 2007). Low insulin
sensitivity and high insulin secretion have been identified
as precursors of T2D (Snitker et al, 2007). 
Lifestyle intervention is associated with dramatic
reductions in visceral fat as well as smaller but still
significant  decreases in subcutaneous fat, body weight, 
body mass index (BMI) and  waist circumference (WC) in 
both men and women (Fujimoto et al, 2007). Diet  and
endurance exercises have been proven to improve BMI,
body composition and body fat distribution, thus delaying
or preventing T2D in individuals with impaired glucose
tolerance (Liao et al, 2002). Modest weight loss, dieting or
dieting and exercise resulted in similar improvements in 
total abdominal fat, subcutaneous adipose tissue and
glycaemic status in postmenopausal  women with T2D
(Giannopoulou et al, 2005). These reports demonstrate the
importance of exercise in the treatment of people with
T2D.
Though therapeutic exercises play a complimentary
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role in the treatment of T2D and its related disorders, 
there is sparse literature on how long the benefits attained 
on adiposity in T2D patients are maintained when
therapeutic exercise is withdrawn. Studies designed to
reduce body adiposity in individuals with T2D are of great
importance as body weight and body fat distribution are
risk factors for diabetes. In non-diabetic individuals,
weight-loss experts have argued that losing excess weight 
during treatment is the first of many steps needed to 
sustain weight loss, but maintaining the lost weight is the 
hard part of obesity treatment for most dieters (Craig,
2007). The age of the patient and duration of the diabetes
have been shown to have an effect on the course of the
disease and its complications (Donaghue et al, 2003;
Scanlon et al, 2005). It is, however,  uncertain how the age
of the patient and duration of the diagnosis are related to
adiposity in T2D patients, especially during the period of
withdrawal from exercises. Based on these considerations, 
the aim of this modified crossover study was to investigate:
1)the effect of withdrawal from therapeutic exercise on
adiposity, and 2) the relationship between the age of the
patient, the duration of diagnosis and adiposity variables of
T2D patients after withdrawal from exercise.
METHOD
Forty-three patients with T2D attending the Specialty
(Diabetic) Clinic of the Aminu Kano Teaching Hospital
(AKTH), Kano, Nigeria, met the eligibility criteria and
volunteered to participate in this study. To qualify for
inclusion in the study the  participant must: (a) be
diagnosed with diabetes by a physician, (b) consent to
measurements, ( c ) be willing to give informed consent, and
(d) must participate in the follow-up phase of the study.
The study was conducted at the outpatient Physiotherapy
Clinic of  AKTH, Kano. 
The Ethical Committee on Research of AKTH, Kano,
approved the study. The consent of the physicians
attending to these patients was also obtained. The study
comprised two research phases spanning a period of 24
weeks, namely: the Exercise Phase (EP) of 12 weeks
duration, and the Follow-Up Phase (FUP), also spanning
12 weeks. 
In the EP, the participants received outlined
therapeutic exercises in addition to the drug and/or diet
regimen that might have been prescribed for them earlier.
This included 3 sessions of endurance and strengthening
exercises per week, with at least a day of rest in between
for twelve consecutive weeks; making 36 sessions. 
There was no exercise intervention for the FUP.
Participants were, however, encouraged to comply with
their prescribed drugs and diet. The FUP included two
visits by the participants within the twelve weeks for re-
assessment – at the end of the 6  and 12   weeks, whichth th
coincided with the 18  and 24  weeks of the entire study.th th
Adiposity Measurements
The following data on the adiposity variables of the
participants were recorded at baseline and subsequently at
the end of the 6 , 12 , 18  and 24  weeks in both the EPth th th th
and FUP.
1. Weight, height and body mass index (BMI): Body
weight was measured in kilograms with a weighing
scale, height was measuredwith a wall-mounted height 
meter in meters and BMI was calculated as weight in
kilograms dividedby height in meters squared (Snitker 
et al, 2007).
2. Waist circumference (WC), hip circumference (HC) 
and waist-hip ratio (WHR): The waist was defined as 
the midpoint between the highest point of the iliac
crest and the lowest point of the costal margin at the
mid-axillary line. Waist circumference was measured 
with an inelastic tape in centimetres. Hip
circumference was measured at the level of the greater
femoraltrochanters in centimetres. The waist-hip ratio 
is the waist circumference divided by the hip
circumference (Fujimoto et al, 2007).
3. Percent body fat (PBF): An Omron BF306 body fat
monitor (Martin et al, 2001) was used to measure the
percentage body fat. 
The WHR and WC were used as measures of  abdominal 
(central) adiposity, while BMI and PBF were used as 
measures of general adiposity (Wannamethee et al, 2005).
Therapeutic Exercises
The duration of each exercise session was 50 - 60 minutes.
This included warm-up and cool-down exercises of 5
minutes each. The participants pedalled a bicycle
ergometer, starting with an intensity of 60% of heart rate
m ax restreserve  (HRR); i.e. [0.6 X (Heart Rate  – Heart Rate ) +
restHeart Rate ] for 20 minutes. This was broken into 2 parts
of 10 minutes each, with a 5-minute break. In addition, they
did 2 rounds of brisk walking with full arm swings, up and
down the length of the gymnasium (10m long), till they
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were exhausted. A minimum of 3 minutes rest was
observed between the 2 laps. Exercises to strengthen the
flexors and extensors of both the upper and lower  limbs
were also carried out. Sixty percent  of the individual’s one
repetition maximum (1RM) was determined and used to
strengthen each group of muscles (Sigal et al, 2004).
Participants performed 2 sets of 10 repetitions, with a
recovery time of 2 minutes between each set. 
Progression of Exercises
The initial intensity of 60% of HRR in the bicycle
ergometry was increased to 65% and 70%  at the beginning
of the 5   and 9  weeks of the study, respectively. Newth th
1RM was determined every fortnight and 60% of that was
utilized thereafter for the strengthening exercises.
Data Analysis
Mean and standard deviations were computed to describe
the participants’ ages, duration of diagnosis and the
variables studied. General linear model repeated measures
were generated to compare the variables in the various
assessment periods. Scheffe’s post-hoc analyses were
computed to locate areas of significance. Pearson’s product
moment correlation coefficients were calculated to reveal
the relationship between the components of adiposity, age
of participants and duration of diagnosis. Significance level
was set at 95%. 
RESULTS
The participants were between 30 - 64 years, with the mean
age and duration of diagnosis being 47.93 ± 9.86 and 5.29
± 4.39 years respectively. General linear  model repeated
measures show significant differences (P < 0.05) for the
components of adiposity that were measured at the
different assessment periods (table 1). Scheffe’s post-hoc
analyses revealed significant improvements (P< 0.05)
between the baseline and the 12  week adiposity variables.th
The means of adiposity variables in the follow-up phase
(from the 12  through the 18  to the 24  week) revealedth th th
increases during the withdrawal period. From the post-hoc 
analyses, these increases were significant for all the
adiposity variables between the 12 -18  and 18 -24  weeks;th th th th
except for HC, which did not witness a significant relapse
until much later, between the 18  and 24  weeks. Duringth th
the follow-up phase, when the relapse occurred, bivariate
correlations (table 2) show direct significant relationships
(P<0.05) between the age of the participants and each of
BMI ® = 0.72) and WC ® = 0.47); and duration of
diagnosis and each of WHR ® = 0.52) and WC ® = 0.59).
Within the same period, however, significant inverse
relationships (P<0.05) were observed between the age of
the participants and each of WHR ® = !0.61) and PBF ® =
-0.43) and between duration of diagnosis and PBF ® =-
0.55). 
Table 1. Comparison of adiposity variables of participants during the exercise and follow-up phases revealing increase in the variables
during follow-up
Adiposity Baseline 12  wk 18  wk 24  wk F P-valueth th th
W t (kg) 83.93 ± 14.60      66.76 ± 8.92      71.74 ± 11.56      82.18 ± 8.31      40.243      <0.05
BMI (kg/m ) 34.84 ± 7.76      27.74 ± 5.37      29.85 ± 8.21      34.18 ± 6.32      63.584      <0.052
W C (cm) 103.90 ± 13.09      91.04 ± 9.73      96.23 ± 9.88      101.90 ± 11.56      211.561       <0.05
HC (cm) 107.41 ± 11.58      106.34 ± 13.11      106.60 ± 8.34      106.94 ± 8.90      302.172      <0.05
W HR 0.96 ± 0.04      0.85 ± 0.07      0.89 ± 0.02      0.95 ± 0.06      27.645      <0.05
PBF (% ) 39.4 ± 7.39      25.03 ± 5.74      27.15 ± 6.44      28.66 ± 6. 64      17.782      <0.05
*All mean changes from one period to another were significant (P < 0.05) except HC where it was significant only between 18  and 24  week.
th th
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Table 2. Correlations between adiposity variables and each of age of participant and duration of diagnosis during the follow-up period
Age Ddiag      W T BMI W C HC W HR PBF
Age 1.00 *0.65     *0.68 *0.72 *0.47 0.21 *-0.61 *-0.43
DDiag   1.00     *0.71 -0.16 *0.59 -0.32 *0.52 *-0.55
W T       1.00 *0.88 *0.56 *0.47 *0.68 *0.71
BMI  1.00 *0.68 0.37 *0.48 *0.53
W C  1.00 *0.71 *0.63 *0.48
HC   1.00 *-0.41   0.26
W HR   1.00 *0.58
PBF   1.00
Notes: *Significant (P <0.05)
W T – weight; BMI – body mass index; W C – waist circumference; HC – hip circumference; W HR – waist-hip-ratio; PBF – percent body fat; DDiag. –
duration of diagnosis.
DISCUSSION 
The principal findings of this study were that the benefits
of therapeutic exercises on adiposity in T2D patients were
not sustained during the period of withdrawal from
exercises. It was also discovered that the age of the
participants and duration of diagnosis were related to the
increase observed in the adiposity variables, with the
exception of hip circumference. Although the achieved
benefits of exercises on adiposity relapsed during the
withdrawal phase, we noticed that the mean of the
variables after 12 weeks of withdrawal did not reach the
baseline level. This signifies that when exercises are
withdrawn from T2D patients, after 12 weeks of moderate,
50-60 minutes, thrice weekly therapeutic exercises, the
achieved benefits are still felt albeit minimally for at least
12 weeks. How much of these benefits are retained,
however, would depend on how old the patient is or how
long the patient has suffered T2D.
The fact that the participants in this study gained
weight, thereby increasing their BMI and other body
composition variables during the follow-up period, may be
because they withdrew from the exercise sessions. This
supports the finding that high levels of physical activity are
necessary for successful weight maintenance (Klem et al,
1997). Evidence also suggests that the level of physical
activity to be undertaken to maintain weight must be
substantial to prevent weight regain (Schoeller et al, 1997).
In a group of overweight and obese women, the addition of
275 minutes per week of physical activity, in addition to a
reduction in energy intake, was important in sustaining a
weight loss of more than 10% (Jakicic et al, 2008). 
Reporting on weight gain over a period of time in non-
diabetic individuals, Devlin et al (2000) claimed that a
comprehensive behavioural weight-control programme,
comprising improved eating habits, lifestyle change and
increased exercise, is widely viewed as the treatment of
choice for overweight and moderately obese individuals.
The authors however claimed that the treatment effects
were not maintained over time.  
Therapeutic exercise has many beneficial effects on
adiposity, and withdrawal from it could bring about a
relapse in the benefits. Lowered blood pressure and blood 
lipids and improvement in glycaemic control are some of 
the benefits that can accrue from maintenance of  weight
loss, and these often keep individuals motivated to
continue with their weight-loss efforts (Craig, 2007). In a
group of Japanese-Americans with impaired glucose
tolerance, it was found that small changes in overall
adiposity as measured by BMI could be associated with
disproportionately larger changes in intra-abdominal fat
following endurance exercises of about one hour, thrice
weekly (Liao et al, 2002). The addition of aerobic exercises
to diet intervention augmented abdominal fat loss, causing
a 13% reduction in visceral adipose tissue, compared with
a 7.5%  reduction with diet-alone intervention
(Giannopoulou et al, 2005). This is because exercise alters
adipose tissue metabolism in individuals, possibly by 
mobilizing free fatty acids from visceral adipose tissues
(Giannopoulou et al, 2005). The increase in body fat
noticed in this study during the withdrawal phase, followed
the principle of reversibility of effects, because the role of
exercises in mobilizing free fatty acids was withdrawn.
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The probable reason for the correlation between some
adiposity variables and age of participant and duration of 
diagnosis could be because aging and long duration of
diagnosis is linked with worsening in adiposity variables.
Studies mainly carried out in young to middle-aged
populations, suggest that WC is a better anthropometric
guide to metabolic risk factor status than BMI, and that 
WC and not BMI explains obesity-related health risks in 
this age group (Zhu et al, 2002; Janssen et al, 2004).
Wannamethee et al (2005) however claimed that in the
elderly, BMI and WC are thebest measures of adiposity for 
predicting the presence of metabolic risk, and suggest that 
WC can be used as a complementary measurement to 
identify health risks in normal-weight and overweight
elderly persons. In this study, however, it was discovered
that during the withdrawal from exercise period, an
increase in WC was significantly and directly related to
both the age of the participant and the duration of
diagnosis of T2D, while an increase in BMI was only
directly related to age. We however found that during the
same period, PBF, a measure of general adiposity
(Wannamethee et al, 2005), was inversely related to both
the age of the participant and the duration of diagnosis.
This indicates the possibility that T2D patients actually
experience a reduction in their general adiposity as the
disorder advances. This may require further confirmation.
According to Ramsay et al (2006), simple measures of
overweight, such as BMI and WC, are good indicators of  
the likelihood of morbidity, and prevention of  weight  gain 
as age advances is likely to reduce morbidity and disability
among older adults.
A larger sample size would probably have provided
increased statistical information to reveal stronger
correlations, but this was not possible because only
individuals who would be able to participate till the end of
the 24  week were recruited. A major strength of this studyth
however was that we were able to discover that an increase
in adiposity also occurs in patients with T2D, following
withdrawal from exercises. Most studies (Klem et al, 1997;
Schoeller et al, 1997; Craig, 2007; Jakicic et al, 2008) in this
area focussed only on non-diabetic, overweight and obese
individuals, with little attention paid to diabetic individuals. 
The clinical implication of this study is that T2D
patients should be encouraged to participate consistently
in therapeutic exercises, considering the fact that a
withdrawal leads to a relapse in the hitherto achieved
benefits. The possibility of an increase in most of the
adiposity variables is higher in older patients and those
with a long-standing history of diabetes. Further research
should be carried out specifically on how long the effects of
exercises are sustained and what factors could lead to
withdrawal from exercises. 
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